The use of a large number of cardiovascular biomarkers, meant to complement the use of
the electrocardiogram, echocardiography cardiac imaging, and clinical symptom …

Measurement of biomarkers has revolutionized the work-up of patients with suspected
cardiovascular disease. The most widely used contemporary cardiovascular biomarkers are …

The use of biomarkers to aid diagnosis and treatment is increasing rapidly as genomics and
proteomics help us expand the number of markers we can use and as an improved …

The incidence of acute myocardial infarction (AMI) has been increasing rapidly in recent
years, seriously endangering human health. Cardiac biomarkers play critical roles in the …

Acute coronary syndromes (ACS) are due to the rupture or erosion of atheromatous plaques.
This produces, depending on plaque size, vascular anatomy and degree of collateral …

Each year, a large number of patients are seen in the Emergency Department with
presentations necessitating investigation for possible acute myocardial infarction. Patients …

Natriuretic peptides (BNP and NT‐proBNP) have been shown to be useful tools for risk
stratification of patients with acute myocardial ischemia encompassing the whole spectrum …

This paper reviews the current contribution of the biochemical marker determination to
clinical cardiology and discusses some important developments in this field. Biochemical …

Heart failure (HF) is a rising epidemic due to the ageing population and progress in all areas
of medicine. Thus, research efforts are made to ensure a timely diagnosis, to improve …

Cardiac biomarkers are integral to the diagnosis and the treatment of acutely ill cardiac
patients. The Working Group on Acute Cardiac Care of the European Society of Cardiology …